Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...
MyGevity announced the nationwide launch of its integrated health data platform designed to bring together at-home genetic testing, biological age measurement, and clinical lab diagnostics in a single ...
The Brighterside of News on MSN
Laser power stations could keep lunar missions running in permanent darkness
Cold, dark crater floors near the Moon’s south pole may hold one of space exploration’s most useful prizes: water ice. Yet ...
Nevada researchers are developing a robotic watering system and a facial-recognition AI model to identify and capture data on ...
Multi-Objective Genetic Algorithms for Optimal Scheduling in Smart Grids: A Case Study with NSGA-III
Abstract: Modern grids are harder to operate than before. Wind and solar are now common, but they are not steady. Output can drop within minutes. Operators must still keep cost low, hold voltage ...
Use of CT is proven to save lives in patients eligible for lung cancer screening, which includes most patients with COPD, said Barr, professor of medicine and epidemiology at Columbia University ...
AI driven ALS research collaboration expands drug discovery capabilities Multimodal platform enhances disease understanding ...
Abstract: With the development of clean energy, microgrid composition and scheduling are becoming increasingly complex. In order to meet the green development while taking into account the economic ...
Morning Overview on MSN
Study: RNA drugs work best when they reshape RNA, not just bind to it
Researchers led by Davide Incarnato at the University of Groningen have demonstrated that the FDA-approved cancer drug ...
An Australian tech expert used AI tools ChatGPT and Google DeepMind’s AlphaFold to design an experimental personalised mRNA ...
Celiac disease is an immune-mediated enteropathy triggered by gluten in genetically predisposed individuals (HLA-DQ2/DQ8), with a global seroprevalence of approximately 1.4%. However, only one in four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results